Growth Metrics

Innoviva (INVA) Share-based Compensation (QoQ) (2010 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Innoviva 1.60 Bn 992.84 Mn 75.83 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -1.73%
Jun 30, 2025 12.81%
Sep 30, 2024 -2.43%
Jun 30, 2024 12.92%
Sep 30, 2023 -5.13%
Jun 30, 2023 -4.88%
Sep 30, 2022 175.33%
Jun 30, 2022 41.51%
Sep 30, 2021 15.32%
Jun 30, 2021 4.21%
Mar 31, 2021 0.89%
Dec 31, 2020 1.36%
Sep 30, 2020 17.60%
Jun 30, 2020 -13.79%
Mar 31, 2020 -10.86%
Dec 31, 2019 -0.20%
Sep 30, 2019 3.16%
Jun 30, 2019 -21.65%
Mar 31, 2019 24.49%
Dec 31, 2018 343.00%
Sep 30, 2018 75.00%
Jun 30, 2018 -136.88%
Mar 31, 2018 -10.63%
Dec 31, 2017 -1.82%
Sep 30, 2017 1.85%
Jun 30, 2017 -3.19%
Mar 31, 2017 33.78%
Dec 31, 2016 9.08%
Sep 30, 2016 -39.53%
Jun 30, 2016 52.41%
Mar 31, 2016 12.97%
Dec 31, 2015 12.40%
Sep 30, 2015 -19.43%
Jun 30, 2015 -5.74%
Mar 31, 2015 40.38%
Dec 31, 2014 -70.90%
Sep 30, 2014 -38.92%
Jun 30, 2014 -42.76%
Mar 31, 2014 126.22%
Dec 31, 2013 -7.18%
Sep 30, 2013 -10.00%
Jun 30, 2013 17.51%
Mar 31, 2013 6.20%
Dec 31, 2012 -1.56%
Sep 30, 2012 -2.49%
Jun 30, 2012 -4.11%
Mar 31, 2012 0.40%
Dec 31, 2011 -9.87%
Sep 30, 2011 9.80%
Jun 30, 2011 13.25%
Mar 31, 2011 18.07%
Dec 31, 2010 4.38%